Commentary: faecal microbiota transplantation-from home brew to holy grail
- PMID: 31850583
- DOI: 10.1111/apt.15553
Commentary: faecal microbiota transplantation-from home brew to holy grail
Comment on
-
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection.Aliment Pharmacol Ther. 2015 May;41(9):835-43. doi: 10.1111/apt.13144. Epub 2015 Mar 1. Aliment Pharmacol Ther. 2015. PMID: 25728808 Clinical Trial.
References
REFERENCES
-
- Cammarota G, Masucci L, Ianiro G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015;41:835-843.
-
- Nicholson MR, Mitchell PD, Alexander E, et al. Efficacy of fecal microbiota transplantation for Clostridium difficile infection in children. Clin Gastroenterol Hepatol. 2019. https://doi.org/10.1016/j.cgh.2019.04.037. [Epub ahead of print]
-
- Madoff SE, Urquiaga M, Alonso CD, Kelly CP. Prevention of recurrent Clostridioides difficile infection: a systematic review of randomized controlled trials. Anaerobe. 2019:102098. https://doi.org/10.1016/j.anaerobe.2019.102098. [Epub ahead of print]
-
- Smillie CS, Sauk J, Gevers D, et al. Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation. Cell Host Microbe. 2018;23:229-240.
-
- Allegretti JR, Mullish BH, Kelly C, Fischer M. The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications. Lancet. 2019;394:420-431.